Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, what assessment he has made of the (a) level of covid-19 vaccine hesitancy amongst women and girls of childbearing age due to concerns around fertility and menstrual disturbance and (b) effectiveness of the Government's strategy to tackle that hesitancy.

The latest assessment on COVID-19 vaccine hesitancy in the United Kingdom is available at the following link:

https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthandwellbeing/datasets/coronavirusandvaccinehesitancygreatbritain

The latest data published in August 2021 shows 4% of adults reported vaccine hesitancy in the UK. In females aged between 16 to 29 years old, hesitancy increased to 9%, whilst for females aged between 30 to 49 years old vaccine hesitancy was at 6%. This is compared to 19% in females aged 16 to 29 years old and 14% for those aged 20 to 49 years old in February 2021.

Whilst vaccine hesitancy has decreased, the Department continues to work closely with our partners to address concerns around pregnancy, breastfeeding and fertility. Our vaccine toolkits for stakeholders, partners and employers provides information on these concerns, and we have shared case stories of women of childbearing age who have received the vaccine before, during or after pregnancy to reassure women who may still be concerned. We have also worked with trusted sources to publicly address and reassure the concerns of younger women. At a local level we have supported webinars and engagement sessions specifically focused on women’s vaccines concerns and tailored to specific demographic groups.